​
Login / Signup
Sarah Wadmann
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 8
Top Topics
Data Analysis
Gene Therapy
Public Health
Case Control
Top Venues
Sociology of health & illness
Medicine, health care, and philosophy
Social studies of science
BioSocieties
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Sarah Wadmann
,
Amalie Martinus Hauge
,
Laura Emdal Navne
Good conduct in a context of rationing: A case study of how frontline professionals deal with distributive dilemmas of novel gene therapies.
Sociology of health & illness
45 (3) (2023)
Sarah Wadmann
,
Amalie Martinus Hauge
,
Laura Emdal Navne
Good conduct in a context of rationing: A case study of how frontline professionals deal with distributive dilemmas of novel gene therapies.
Sociology of health & illness
(2023)
Sarah Wadmann
,
Amalie Martinus Hauge
,
Laura Emdal Navne
Good conduct in a context of rationing: A case study of how frontline professionals deal with distributive dilemmas of novel gene therapies.
Sociology of health & illness
45 (3) (2023)
Sarah Wadmann
,
Amalie Martinus Hauge
,
Laura Emdal Navne
Good conduct in a context of rationing: A case study of how frontline professionals deal with distributive dilemmas of novel gene therapies.
Sociology of health & illness
45 (3) (2023)
Sarah Wadmann
,
Mette Hartlev
,
Klaus Hoeyer
The life and death of confidentiality: a historical analysis of the flows of patient information.
BioSocieties
(2022)
Amalie Martinus Hauge
,
Eva Iris Otto
,
Sarah Wadmann
The sociology of rationing: Towards increased interdisciplinary dialogue - A critical interpretive literature review.
Sociology of health & illness
44 (8) (2022)
Sara Green
,
Line Hillersdal
,
Jette Holt
,
Klaus Hoeyer
,
Sarah Wadmann
The practical ethics of repurposing health data: how to acknowledge invisible data work and the need for prioritization.
Medicine, health care, and philosophy
(2022)
Sarah Wadmann
,
Amalie Martinus Hauge
Strategies of stratification: Regulating market access in the era of personalized medicine.
Social studies of science
51 (4) (2021)